XML 34 R24.htm IDEA: XBRL DOCUMENT

NONCONTROLLING INTEREST

6 Months Ended

Jun. 30, 2022

On July 28, 2016, the Company formed BioCorRx Pharmaceuticals, Inc., a Nevada Corporation, for the purpose of developing certain business lines. In connection with the formation, the, the newly formed sub issued 24.2% ownership to current or former officers of the Company with the Company retaining 75.8%. From inception through December 31, 2017, there were no significant transactions. In 2018, BioCorRx Pharmaceuticals, Inc. began operations.

A reconciliation of the BioCorRx Pharmaceuticals, Inc. non-controlling loss attributable to the Company:

Net loss attributable to the non-controlling interest for the three months ended June 30, 2022:

Net loss	$	(7,257	)
Average Non-controlling interest percentage of profit/losses		24.2	%
Net loss attributable to the non-controlling interest	$	(1,756	)

Net loss attributable to the non-controlling interest for the six months ended June 30, 2022:

Net loss	$	(9,533	)
Average Non-controlling interest percentage of profit/losses		24.2	%
Net loss attributable to the non-controlling interest	$	(2,307	)

The following table summarizes the changes in non-controlling interest for the six months ended June 30, 2022:

Balance, December 31, 2021	$	(117,838	)
Net loss attributable to the non-controlling interest		(2,307	)
Balance, June 30, 2022	$	(120,145	)

Net loss attributable to the non-controlling interest for the three months ended June 30, 2021:

Net loss	$	(2,860	)
Average Non-controlling interest percentage of profit/losses		24.2	%
Net loss attributable to the non-controlling interest	$	(692	)

Net loss attributable to the non-controlling interest for the six months ended June 30, 2021:

Net loss	$	(6,067	)
Average Non-controlling interest percentage of profit/losses		24.2	%
Net loss attributable to the non-controlling interest	$	(1,468	)

The following table summarizes the changes in non-controlling interest for the six months ended June 30, 2021:

Balance, December 31, 2020	$	(115,454	)
Net loss attributable to the non-controlling interest		(1,468	)
Balance, June 30, 2021	$	(116,922	)